Ischemic heart disease

Summary of American societies’ clinical guidelines for the clinical and therapeutic management of patients with stable coronary disease.

Comparative study of mid-to-long-term experience in a single center on grafting patent stented vessels versus leaving them ungrafted in patients undergoing surgical revascularization.

Results from the Swedish registry SWEDENHEART on the comparative outcomes of coronary intervention versus surgical revascularization in left main coronary artery disease and a contrast with findings from major clinical trials.

A systematic review and meta-analysis of observational studies comparing the use of double internal mammary artery (BITA) with saphenous vein (SV) versus BITA with radial artery (RA) in surgical treatment for triple-vessel coronary artery disease. Long-term survival was evaluated with follow-up up to 12 years.

Comparative meta-analysis of prospective studies on urgent revascularization in patients with multivessel disease presenting specifically as Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS), via coronary artery bypass grafting or percutaneous intervention.

This meta-analysis, encompassing 6 clinical trials, compares percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in cases of left main coronary artery disease or multivessel disease, presenting results stratified according to the SYNTAX score.

This is a single-center study from a Korean group examining long-term outcomes of complete surgical revascularization without extracorporeal circulation from an anatomic/angiographic or functional perspective.

A sub-analysis of the COMPASS study evaluating one-year patency of various types of coronary grafts through CT angiography, considering technical aspects of revascularization strategy configuration.

This retrospective study adjusted by propensity score analysis compares mid- to long-term revascularization outcomes in multivessel disease patients treated with conventional off-pump coronary artery bypass grafting (OPCAB), percutaneous coronary intervention (PCI), and hybrid revascularization.